D57.811 Other sickle-cell disorders with acute chest syndrome

Name of the Condition

• Other sickle-cell disorders with acute chest syndrome

Summary

Other sickle-cell disorders with acute chest syndrome represent a subtype of inherited blood conditions characterized by abnormal hemoglobin, leading to red blood cells that assume a rigid, sickle shape. These malformed cells can obstruct blood flow, resulting in pain, organ damage, and other complications. The presence of acute chest syndrome indicates a severe respiratory manifestation, distinguishing this subtype from stable forms of the disorder.

Causes

Other sickle-cell disorders arise from mutations in the hemoglobin gene (HBB), which alters hemoglobin structure. These genetic mutations follow an autosomal recessive inheritance pattern, requiring two copies of the mutated gene (one from each parent) for the disorder to develop. Acute chest syndrome may be triggered by infection, fat embolism, or vaso-occlusion in the lungs.

Risk Factors

• Family history of sickle-cell disorders
• Ethnic background, particularly individuals of African, Mediterranean, Middle Eastern, Indian, or Caribbean descent
• Inheriting one sickle-cell gene (sickle cell trait) increases the risk of passing the disorder to offspring
• Prior episodes of acute chest syndrome
• Exposure to respiratory infections or environmental triggers

Symptoms

• Severe chest pain
• Shortness of breath (dyspnea)
• Cough (may produce sputum or blood)
• Fever
• Rapid breathing (tachypnea)
• Low oxygen levels (hypoxemia)
• Fatigue and weakness due to anemia

Diagnosis

Diagnosis involves clinical evaluation of respiratory symptoms, chest imaging (e.g., X-ray or CT scan) to detect lung abnormalities, and blood tests to identify sickle-shaped red blood cells. Additional tests may include arterial blood gas analysis to assess oxygenation and hemoglobin electrophoresis to confirm the sickle-cell subtype.

Treatment Options

Treatment focuses on managing respiratory distress, preventing complications, and addressing underlying sickle-cell pathology. Interventions may include supplemental oxygen, antibiotics for infection, pain management, blood transfusions, and hydration. Severe cases may require mechanical ventilation or exchange transfusions.

Prognosis and Follow-Up

Prognosis depends on the severity of lung involvement and timeliness of treatment. Acute chest syndrome can be life-threatening, but early intervention improves outcomes. Long-term follow-up includes monitoring for recurrent episodes, lung function, and organ damage. Preventive measures, such as vaccinations and avoiding triggers, are emphasized.

Complications

• Respiratory failure
• Pneumonia or lung infection
• Pulmonary hypertension
• Chronic lung damage
• Multi-organ dysfunction due to hypoxia

Lifestyle & Prevention

• Avoid respiratory infections through vaccinations (e.g., flu, pneumonia)
• Stay hydrated to reduce blood viscosity
• Avoid extreme temperatures and high altitudes
• Seek prompt treatment for respiratory symptoms
• Follow prescribed medications (e.g., hydroxyurea) to reduce crisis frequency

When to Seek Professional Help

Seek immediate medical attention for chest pain, difficulty breathing, fever, or sudden worsening of symptoms. Early intervention is critical to prevent severe complications.

Tips for Medical Coders

Document the presence of acute chest syndrome and its clinical features (e.g., respiratory symptoms, imaging findings) to support coding. Ensure differentiation from other sickle-cell complications and confirm the subtype (D57.811) is appropriate based on the clinical presentation.